Plasmacytoid dendritic cells sense hepatitis C virus–infected cells, produce interferon, and inhibit infection
暂无分享,去创建一个
F. Chisari | S. Wieland | U. Garaigorta | P. Gastaminza | Stefan Wieland | Francis V Chisari | Shinichi Asabe | M. Isogawa | Pablo Gastaminza | Ken Takahashi | Ken Takahashi | Urtzi Garaigorta | Masanori Isogawa | S. Asabe
[1] D. Burton,et al. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge , 2008, Nature Medicine.
[2] D. Graham,et al. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α , 2007, Proceedings of the National Academy of Sciences.
[3] F. Chisari,et al. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Bartenschlager,et al. Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations , 2001, Journal of Virology.
[5] Stanley M Lemon,et al. Interferon regulatory factor‐3 activation, hepatic interferon‐stimulated gene expression, and immune cell infiltration in hepatitis C virus patients , 2008, Hepatology.
[6] R. Steinman,et al. Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion , 2000, Journal of Virology.
[7] L. Wodicka,et al. Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] Maxey C M Chung,et al. Hepatocellular carcinoma: From bedside to proteomics , 2001, Proteomics.
[9] J. Lifson,et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. , 2005, The Journal of clinical investigation.
[10] S. Akira,et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.
[11] S. Strom,et al. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. , 2007, Toxicology and applied pharmacology.
[12] Stefano Volinia,et al. Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.
[13] G. Trinchieri,et al. Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.
[14] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[15] M. Mizokami,et al. Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon , 2005, Journal of Virology.
[16] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[17] Yong‐jun Liu,et al. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.
[18] F. Chisari,et al. Replication of a hepatitis C virus replicon clone in mouse cells , 2006, Virology Journal.
[19] M. Shiina,et al. Cell culture–produced hepatitis C virus impairs plasmacytoid dendritic cell function , 2007, Hepatology.
[20] K. Conzelmann,et al. Replication-Dependent Potent IFN-α Induction in Human Plasmacytoid Dendritic Cells by a Single-Stranded RNA Virus1 , 2004, The Journal of Immunology.
[21] Michael Gale,et al. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA , 2008, Nature.
[22] T. Wakita,et al. Hepatitis C virus–infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells , 2008, Hepatology.
[23] R. Gorchakov,et al. Noncytopathic Replication of Venezuelan Equine Encephalitis Virus and Eastern Equine Encephalitis Virus Replicons in Mammalian Cells , 2005, Journal of Virology.
[24] M. Mizokami,et al. Genotype 2a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG2 and IMY-N9 Cells* , 2004, Journal of Biological Chemistry.
[25] S. Lemon,et al. Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees , 2004, Journal of Virology.
[26] R. Lanford,et al. DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection , 2001, Journal of Virology.
[27] M. Mizokami,et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. , 2003, Gastroenterology.
[28] A. Shavinskaya,et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[29] F. Chisari. Unscrambling hepatitis C virus–host interactions , 2005, Nature.
[30] Douglas T. Golenbock,et al. Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition1 , 2006, The Journal of Immunology.
[31] T. Santantonio,et al. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection , 2005, Hepatology.
[32] V. Hornung,et al. Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells , 2001 .
[33] William M. Lee,et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[34] F. Chisari,et al. Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost , 2006, Journal of Virology.
[35] D. Burton,et al. Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[37] N. Hayashi,et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. , 2004, The Journal of infectious diseases.